title: human iPSC control
design: We created LMNB2-inactivated isogenic human iPSC lines, and differentiated both control and LMNB2-KO human iPSC to cardiomyocytes in vitro via WNT signaling modulation. We then performed single-cell RNAseq using 10x platform with control and LMNB2 KO human iPSCs and derived cardiomyocytes.